190 related articles for article (PubMed ID: 1326621)
1. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
Pick CG; Paul D; Pasternak GW
J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
[TBL] [Abstract][Full Text] [Related]
2. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
[TBL] [Abstract][Full Text] [Related]
3. Naloxone benzoylhydrazone (NalBzoH) analgesia.
Paul D; Levison JA; Howard DH; Pick CG; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1990 Nov; 255(2):769-74. PubMed ID: 2173757
[TBL] [Abstract][Full Text] [Related]
4. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
Rady JJ; Roerig SC; Fujimoto JM
J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
Paul D; Pick CG; Tive LA; Pasternak GW
J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
Takemori AE; Portoghese PS
J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
[TBL] [Abstract][Full Text] [Related]
7. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
Pick CG; Nejat RJ; Pasternak GW
J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
[TBL] [Abstract][Full Text] [Related]
8. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
Ward SJ; Takemori AE
J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
[TBL] [Abstract][Full Text] [Related]
9. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
Vaught JL; Mathiasen JR; Raffa RB
J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
[TBL] [Abstract][Full Text] [Related]
10. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
Song ZH; Takemori AE
J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788
[TBL] [Abstract][Full Text] [Related]
11. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
Rady JJ; Elmer GI; Fujimoto JM
J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
[TBL] [Abstract][Full Text] [Related]
12. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
Suh HH; Tseng LF
J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
[TBL] [Abstract][Full Text] [Related]
14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
15. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
De Souza EB; Schmidt WK; Kuhar MJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
[TBL] [Abstract][Full Text] [Related]
16. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
[TBL] [Abstract][Full Text] [Related]
17. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
18. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
Zimmerman DM; Leander JD; Reel JK; Hynes MD
J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
[TBL] [Abstract][Full Text] [Related]
19. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
Fang FG; Fields HL; Lee NM
J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA; Paul D; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]